This educational grant supports activities that explore new mechanisms and emerging treatment options for metastatic castration resistant prostate cancer. It aims to advance knowledge and education in the oncology field related to mCRPC therapies and research.
Eligibility criteria are not specified for this educational grant opportunity.
